威海华东数控股份有限公司 2020 年第一季度报告全文 2020 年第一季度报告 2020 年 04 月 1 威海华东数控股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人连小明、主管会计工作负责人张金刚及会计机构负责人（会计主管人员）肖 崔英声明：保证季度报告中财务报表的真实、准确、完整。 2 威海华东数控股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 1、公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | 项 目 | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 34,292,937.95 | 25,203,337.84 | 36.07% | | 归属于上市公司股东的净利润（元） | -9,514,095.91 | -15,572,525.27 | ...

Financial Performance - The company's operating revenue for 2019 was ¥161,378,299.22, representing a 94.23% increase compared to ¥83,084,147.63 in 2018[18]. - The net profit attributable to shareholders for 2019 was ¥26,635,925.07, a significant recovery from a loss of ¥574,995,740.16 in 2018, marking a 104.63% improvement[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥78,943,999.98, which is an 83.96% reduction in losses compared to ¥492,147,847.51 in 2018[18]. - The company achieved an operating revenue of CNY 161.38 million in 2019, representing a year-on-year increase of 94.23%[33]. - The net profit attributable to shareholders was CNY 26.64 million, a year-on-year growth of 104.63%[33]. - The weighted average return on equity increased to 22.66%, up from -158.94% in the previous year, marking a 181.60% improvement[19]. - The company recorded a non-operating income of CNY 105.58 million, compared to a loss of CNY -82.85 million in 2018[26]. - The company reported a significant impairment loss of CNY 39.63 million due to asset impairment provisions, impacting net profit[33]. - The company's operating revenue increased by 94.23% compared to the previous year[47]. - The net profit attributable to the parent company was 26.64 million yuan, an increase of 60.16 million yuan, reflecting a growth of 104.63% year-on-year, driven by increased operating revenue and reduced depreciation expenses[72]. Operational Highlights - The company sold 1,036 units in 2019, a 48.42% increase compared to 698 units in 2018[33]. - The total assets decreased by 21.87% to CNY 603.10 million from CNY 771.96 million in 2018[19]. - The net cash flow from operating activities was CNY 22.39 million, a significant recovery from a negative cash flow of CNY -61.64 million in the previous year[19]. - Inventory levels increased by 10.08% to 961 units in 2019, up from 873 units in 2018[33]. - The company achieved a CNC equipment automation rate of 60%, leading the industry in China[44]. - The company has established a sales network with a focus on regional distributors and direct sales, enhancing market penetration[36]. - The company aims to develop high-speed, high-precision, multi-axis, and environmentally friendly CNC machine tools to replace imports[37]. - The company is focused on R&D and production of CNC machine tools that meet national policy requirements and market demand[49]. - The company is the largest manufacturer of CNC gantry guideway grinding machines in China, with a production scale that leads the industry[50]. Strategic Plans and Goals - The company plans not to distribute cash dividends or issue bonus shares for the year[7]. - The company plans to continue developing new products and enhancing marketing efforts to adapt to market demands[33]. - The 2020 revenue target is set at 160 million yuan, focusing on structural adjustment, quality improvement, and management enhancement[55]. - The company plans to enhance the development and production of high-value-added CNC precision universal cylindrical grinding machines and CNC surface grinding machines[56]. - The company aims to expand its marketing efforts by strengthening traditional sales channels and leveraging new media for online marketing[59]. - The company will focus on industries with high growth potential, such as 5G, engineering machinery, aerospace, and new energy vehicles[63]. - The company emphasizes strict cost control and efficiency improvement as key priorities for 2020[64]. - The company is committed to enhancing product quality through rigorous quality control measures and employee training[58]. - The company will implement a unified material distribution mechanism to improve production planning accuracy and material delivery timeliness[66]. Governance and Compliance - The company is under the control of Wei Gao Medical Investment, which holds a 17.51% stake, influencing the board's decisions significantly[16]. - The company has engaged Xinyong Zhonghe Accounting Firm for auditing, ensuring the accuracy of its financial reports[17]. - The company guarantees the independence of its operations, assets, and finances post-equity changes, committing to strict adherence to this principle[127]. - The company has committed to avoiding and minimizing related party transactions to ensure fair market practices[124]. - The company reported a commitment to avoid related party transactions that could harm the interests of minority shareholders, ensuring compliance with legal and regulatory requirements[125]. - The company has not engaged in any major related party transactions during the reporting period[144]. - The company has not engaged in any business that competes with its subsidiaries, ensuring no conflicts of interest arise[126]. - The board and supervisory board have provided explanations regarding the non-standard audit report, which can be found on the official information disclosure website[129]. Market and Industry Context - The CNC machine tools industry is expected to see domestic high-end products dominate the market in the next 10-15 years[37]. - The machine tool industry is experiencing intense competition, particularly in the price and service aspects, which could impact the company's market position[112]. - The company has been actively expanding its customer base across various industries, including railways, automotive, and aerospace, to mitigate risks associated with macroeconomic fluctuations[111]. - The company has established long-term partnerships with renowned research institutions and universities to enhance its technological capabilities[114]. Management and Leadership - The company experienced a management change with the appointment of Wang Haibo as the new general manager effective February 28, 2019, following the retirement of the previous general manager[188]. - The current board includes experienced professionals with backgrounds in banking and management, enhancing the company's strategic direction[189]. - The company has a diverse leadership team, with members holding advanced degrees and significant industry experience, which supports its operational effectiveness[191]. - The management team is committed to expanding market reach and exploring potential mergers and acquisitions to drive growth[191]. - The leadership changes are part of a broader strategy to align the company's goals with market demands and operational capabilities[188]. Research and Development - The company has invested over 5% of its sales revenue annually in technology development to support rapid growth and innovation[114]. - The company is investing 50 million RMB in R&D for new technologies aimed at enhancing product efficiency[198]. - The company has invested 200 million RMB in research and development, focusing on advanced medical technologies and solutions[199]. - R&D expenses decreased by 9.04% to ¥7,229,793.83, influenced by the company's product transformation and reduced personnel costs[91]. - New product development efforts have led to the introduction of three innovative medical devices, expected to contribute an additional 300 million RMB in revenue[200]. Future Outlook - The company provided guidance for the next quarter, expecting revenue to grow by 10% to 1.32 billion RMB[198]. - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% based on new product launches and market expansion strategies[199]. - The management emphasized a focus on improving operational efficiency, targeting a 10% reduction in costs by the end of the next fiscal year[198]. - The company is planning to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[199]. - A strategic acquisition of a local competitor is anticipated to enhance the company's product portfolio and increase market competitiveness[200].

Financial Performance - The company's operating revenue for 2019 was ¥161,378,299.22, representing a 94.23% increase compared to ¥83,084,147.63 in 2018[18]. - The net profit attributable to shareholders for 2019 was ¥26,635,925.07, a significant recovery from a loss of ¥574,995,740.16 in 2018, marking a 104.63% improvement[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥78,943,999.98, which is an 83.96% reduction in losses compared to ¥492,147,847.51 in 2018[18]. - The company achieved operating revenue of CNY 161.38 million in 2019, representing a year-on-year increase of 94.23%[32]. - The net profit attributable to shareholders was CNY 26.64 million, a year-on-year growth of 104.63%[32]. - The weighted average return on equity increased to 22.66%, up from -158.94% in the previous year, marking a 181.60% improvement[25]. - The company reported a significant increase in cash flow from investing activities, reaching 221.36 million yuan, up 2695.85% year-on-year, mainly from asset disposals[72]. - The company’s cash and cash equivalents at year-end were 92.37 million yuan, a 346.01% increase from the beginning of the year, reflecting cash inflows from asset disposals[68]. - The company reported a net profit margin of 12%, up from 10% in the previous year, indicating improved operational efficiency[187]. Business Strategy and Operations - The company has not made any changes to its main business since its listing[15]. - The company emphasizes the uncertainty of achieving its 2020 operational goals due to market conditions and team efforts[6]. - The company has adjusted its business strategy to develop new products and enhance marketing efforts, leading to increased sales volume and reduced costs[32]. - The company aims to focus on high-speed, high-precision, multi-axis, composite, and environmentally friendly CNC machine tools for sustainable development[36]. - The company is committed to independent innovation and aims to replace imports with domestically produced high-end CNC machine tools[36]. - The company is actively pursuing new strategies to enhance its competitive position in the market, focusing on technological advancements and product development[181]. - The company is exploring potential acquisitions to enhance its product portfolio, with a budget of 300 million RMB allocated for this purpose[187]. Market and Sales Performance - The company sold 1,036 units in 2019, a 48.42% increase compared to 698 units in 2018[32]. - The revenue from CNC machine tool products was ¥113,253,069.01, with a significant year-on-year growth of 134.84%[78]. - Sales in the East China region surged to ¥79,267,779.97, marking a 129.13% increase year-on-year[78]. - The company reported a 100.76% increase in revenue from international markets, totaling ¥26,493,739.87[78]. - Key industries for market expansion include 5G, construction machinery, aerospace, and new energy vehicles[58]. Financial Management - The company has actively managed its financials, reducing operating losses and improving its financial condition by managing accounts receivable and idle assets[43]. - The company reported a decrease in management expenses by 75.97% year-on-year, amounting to 26.97 million yuan, due to reduced depreciation and repair costs[64]. - The company’s financial expenses decreased by 50.23% year-on-year to 11.80 million yuan, attributed to a reduction in borrowing scale and financing costs[64]. - Operating cash inflow increased by 84.03% to ¥134,205,368.95, while operating cash outflow decreased by 16.91% to ¥111,810,716.75, resulting in a net cash flow from operating activities of ¥22,394,652.20, a turnaround from a loss of ¥61,639,503.55[89][90]. Corporate Governance and Compliance - The company has committed to avoiding and minimizing related party transactions to ensure fair market practices[116]. - The company ensures that all related party transactions will be conducted fairly and in accordance with legal procedures[120]. - The board and supervisory board have addressed the non-standard audit report with explanations available on the official website[122]. - The company has not reported any non-compliance with the commitments made regarding related party transactions[120]. Research and Development - The company holds 171 patents, including 32 invention patents and 136 utility model patents, showcasing its strong R&D capabilities[38]. - Research and development expenses decreased by 9.04% to ¥7,229,793.83 due to a shift in product focus and reduced personnel costs[86]. - The company invested over 5% of its sales revenue annually in technology development, supporting rapid growth[108]. Human Resources - The total number of employees in the company is 398, with 257 in production, 30 in sales, 19 in technical roles, 16 in finance, and 76 in administration[195]. - The company emphasizes employee training, implementing various training programs to enhance technical skills and theoretical knowledge[198]. - The company has not engaged in any labor outsourcing during the reporting period, maintaining all operations in-house[199]. Shareholder Information - The company’s total shares amount to 307,495,600, with 4.71% of shares being subject to restrictions[160]. - The largest shareholder, Weihai Weigao International Medical Investment Holding Co., Ltd., holds 17.50% of the shares, totaling 53,825,800 shares[165]. - The company has not experienced any changes in its controlling shareholder during the reporting period[167].

Financial Performance - Operating revenue for the reporting period increased by 61.57% to CNY 32,587,573.24, while year-to-date revenue rose by 83.95% to CNY 110,904,961.70[7] - Net profit attributable to shareholders increased by 168.18% to CNY 38,714,269.35 for the reporting period, and by 105.39% to CNY 9,085,111.20 year-to-date[7] - Basic and diluted earnings per share rose by 172.22% to CNY 0.13 for the reporting period[7] - Total operating revenue for Q3 2019 was CNY 32,587,573.24, a 61.2% increase from CNY 20,169,057.64 in the same period last year[38] - Net profit for Q3 2019 was CNY 36,549,512.06, compared to a net loss of CNY 62,832,066.09 in Q3 2018[38] - Earnings per share for Q3 2019 was CNY 0.13, recovering from a loss of CNY 0.18 per share in the same quarter last year[38] - Net profit for the period was ¥2,591,613.93, a significant recovery from a net loss of ¥185,866,242.54 in the previous period[42] - Earnings per share improved to ¥0.03 from a loss of ¥0.55, indicating a positive turnaround in profitability[42] - The company achieved a comprehensive income total of ¥2,591,613.93, recovering from a comprehensive loss of ¥185,866,242.54 in the prior period[42] Asset and Liability Management - Total assets decreased by 17.39% to CNY 637,741,434.72 compared to the end of the previous year[7] - The total number of shareholders at the end of the reporting period was 22,149[11] - The largest shareholder, Weihai Weigao International Medical Investment Holding Co., Ltd., holds 17.50% of the shares[11] - The total liabilities decreased to CNY 563,607,510.05 from CNY 700,863,290.48, indicating a reduction of approximately 19.6%[32] - The company's total equity attributable to shareholders of the parent company increased to CNY 113,734,500.96 from CNY 104,206,729.14, reflecting a growth of approximately 9.3%[32] - The company's total liabilities to total assets ratio improved to approximately 88.3% from 90.7%[32] Cash Flow Analysis - The company reported a net cash flow from operating activities of -CNY 6,463,638.27, a decrease of 52.27% compared to the same period last year[7] - Cash flow from operating activities showed a net outflow of ¥16,497,771.47, an improvement from a larger outflow of ¥50,582,598.24 in the previous period[46] - Cash inflow from operating activities totaled 110,828,628.99 CNY, up from 61,068,894.52 CNY year-over-year, reflecting a growth of approximately 81.6%[48] - Cash outflow from operating activities increased to 190,751,714.10 CNY from 69,697,189.71 CNY, representing a rise of about 173.5%[48] - The net cash flow from investing activities was 218,825,437.42 CNY, significantly higher than 64,910,500.00 CNY in the previous period, marking an increase of approximately 237.5%[48] - Cash inflow from investing activities reached 225,825,437.42 CNY, compared to 65,810,500.00 CNY previously, showing a growth of around 243.5%[48] - The net cash flow from financing activities was -136,701,764.59 CNY, worsening from -57,019,131.62 CNY in the prior period[48] Expense Management - Operating costs rose to ¥101,704,136.01, reflecting a 30.94% increase due to higher sales volume[14] - Sales expenses surged by 95.06% to ¥12,957,582.25, driven by increased employee compensation and promotional costs[14] - Management expenses dropped significantly by 64.07% to ¥24,982,042.56, due to reduced depreciation and the exclusion of a subsidiary from consolidation[14] - Research and development expenses decreased by 46.68% to ¥3,044,265.15, also impacted by the exclusion of a subsidiary[14] - Research and development expenses for Q3 2019 were CNY 582,514.81, down from CNY 1,366,728.54 in Q3 2018, a decrease of 57.4%[38] Other Notable Events - The company did not engage in any repurchase transactions during the reporting period[12] - The company reported an asset disposal gain of ¥59,811,716.89, a substantial increase of 6711.07% compared to the previous year[14] - The company reported a significant asset disposal gain of ¥59,811,716.89, contributing positively to the overall profit[42] - The company plans to focus on market expansion and new product development in the upcoming quarters[39]

Financial Performance - The company's operating revenue for the first half of 2019 was ¥78,317,388.46, representing a 95.20% increase compared to ¥40,122,459.58 in the same period last year[23]. - The net profit attributable to shareholders of the listed company improved to -¥29,629,158.15, a 73.49% reduction in losses from -¥111,776,414.44 year-on-year[23]. - The net cash flow from operating activities was -¥10,034,133.20, showing a 72.91% improvement compared to -¥37,040,034.72 in the previous year[23]. - The basic and diluted earnings per share improved to -¥0.10, a 72.22% reduction in losses from -¥0.36 in the same period last year[23]. - The company reported a total comprehensive loss of -29,629,158.15 CNY for the current period, compared to a loss of -4,328,739.98 CNY in the previous period[140]. - The company reported a net profit attributable to the parent company of -574.9957 million yuan for 2018, with cumulative undistributed profits of -1,007.458 million yuan[73]. - The company’s financial performance indicates a need for strategic reassessment and potential restructuring to address ongoing losses[147]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥862,096,906.82, an increase of 11.68% from ¥771,962,940.60 at the end of the previous year[23]. - The net assets attributable to shareholders decreased by 28.12% to ¥74,899,176.54 from ¥104,206,729.14 at the end of the previous year[23]. - The company’s total liabilities increased by 69.44% to ¥481,002,300.71 from ¥283,883,817.75, primarily due to asset disposal proceeds[45]. - Current assets increased to ¥465,833,439.13 from ¥361,863,947.60, representing a growth of approximately 28.7%[124]. - Total liabilities increased to ¥824,633,549.28 from ¥700,863,290.48, reflecting a rise of approximately 17.6%[126]. - The total equity attributable to shareholders decreased to ¥74,899,176.54 from ¥104,206,729.14, a decline of about 28.0%[126]. Research and Development - The company invests over 5% of its sales revenue annually in technology development to support rapid growth[14]. - The company has established long-term partnerships with domestic research institutions and universities to enhance its technological capabilities[14]. - The company holds 171 patents, including 32 invention patents, and has established several provincial-level R&D platforms[33]. - The company has developed a range of high-speed CNC machine tools, receiving positive feedback from users[34]. - Research and development expenses decreased by 43.31% to ¥2,461,750.34 from ¥4,342,354.75, influenced by the exclusion of a subsidiary from the consolidated financial statements[45]. Market and Competition - The company faces industry and market risks due to the cyclical nature of the machine tool industry, which is influenced by downstream manufacturing investment demand[13]. - The CNC machine tool industry remains sluggish, with key metrics such as new orders and revenue declining year-on-year[30]. - The company faces risks from market competition, particularly in the CNC machine tool sector, which is characterized by price and service competition[64]. - The company recognizes the importance of adapting to market changes and enhancing management efficiency to improve overall performance[38]. Strategic Plans - The company aims to achieve a main business income of 160 million yuan in 2019[39]. - The company plans to enhance product technology structure and focus on high-speed, high-precision, multi-axis, composite, and environmentally friendly CNC machine tools[39]. - The company will strengthen its marketing network and increase sales efforts in key domestic and international regions[42]. - The company intends to improve its asset structure and profitability by actively disposing of assets[43]. - The company is committed to maintaining a competitive edge by developing new products with core competitiveness[41]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 21,646[107]. - The largest shareholder, Weihai Weigao International Medical Investment Holding Co., Ltd., holds 17.50% of the shares, totaling 53,825,800 shares[107]. - The number of restricted shares increased by 3,624,341, bringing the total restricted shares to 14,497,363, which represents 4.71% of the total shares[104]. - The total number of unrestricted shares decreased by 3,624,341, resulting in 292,998,237 unrestricted shares, which accounts for 95.29% of the total shares[104]. Legal and Compliance - The company has a total of 65 unresolved litigation and arbitration cases, with a total amount involved of 148.7768 million yuan, accounting for 142.77% of the company's latest audited net assets attributable to shareholders[77]. - The company aims to enhance its legal work level to effectively handle litigation matters and protect its legal rights[73]. - The company has not conducted an audit for its half-year financial report[71]. Financial Reporting and Accounting - The company adheres to the accounting standards set by the Ministry of Finance, ensuring accurate reflection of its financial status and cash flows[159]. - The company has no significant doubts regarding its ability to continue as a going concern for the next 12 months[158]. - The accounting period for the company is from January 1 to December 31 each year[160].

Financial Performance - The company's operating revenue for Q1 2019 was ¥25,203,337.84, representing an increase of 8.85% compared to ¥23,153,339.98 in the same period last year[7] - The net profit attributable to shareholders was a loss of ¥15,572,525.27, which is a 50.28% improvement from a loss of ¥31,319,711.61 in the previous year[7] - The company reported a net loss of ¥1,023,030,553.70 in retained earnings as of March 31, 2019, compared to a loss of ¥1,007,458,028.43 at the end of 2018[40] - The company achieved other income of ¥117,500.00 during the current period, contributing positively to the overall financial performance[46] - The company reported a total comprehensive loss of -¥17,034,001.12, an improvement from -¥36,127,998.98, showing a 52.96% reduction in comprehensive losses[46] Cash Flow - The net cash flow from operating activities improved significantly, with a net outflow of ¥6,718,895.73, a 71.88% reduction from ¥23,896,826.24 in the same period last year[7] - Cash and cash equivalents at the end of the reporting period amounted to 7.80 million yuan, a decrease of 12.91 million yuan or 62.32% compared to the beginning of the period, primarily due to tax payments and employee compensation[19] - The total cash inflow from operating activities was ¥22,743,149.89, compared to ¥31,648,537.83 in the previous period, indicating a decline in overall cash inflow[53] - The total cash outflow from operating activities was ¥17,944,093.69, down from ¥26,156,057.22, reflecting improved cost management[53] - The net cash flow from operating activities for the current period is ¥4,799,056.20, a decrease of 12.6% compared to ¥5,492,480.61 in the previous period[53] Assets and Liabilities - The total assets at the end of the reporting period were ¥738,520,346.19, down 4.33% from ¥771,962,940.60 at the end of the previous year[7] - Current assets totaled ¥335,964,522.77, down 7.15% from ¥361,863,947.60 at the end of 2018[38] - Total liabilities were ¥684,246,688.36, reflecting a decrease of 2.73% from ¥700,863,290.48[40] - The company's equity attributable to shareholders decreased to ¥88,842,212.70, down 14.73% from ¥104,206,729.14[40] - Short-term borrowings increased slightly to ¥205,471,600.00, compared to ¥204,074,050.00 at the end of 2018[40] Expenses - Sales expenses increased by 32.12%, totaling ¥2,862,400, primarily due to higher sales commissions[16] - Management expenses decreased by 63.22%, amounting to ¥5,282,400, due to reduced depreciation and the exclusion of a subsidiary from the consolidated financial statements[16] - Total operating costs decreased to ¥45,781,868.50 from ¥60,014,645.04, a reduction of 23.73%[46] - Research and development expenses were ¥1,255,334.65, slightly decreased from ¥1,627,061.25, indicating a focus on cost management[46] Future Outlook - The company expects a net profit for the first half of 2019 to be between -45.00 million yuan and -25.00 million yuan, compared to a net profit of -111.78 million yuan in the same period of 2018[27] - The company anticipates that the effects of measures to restore production and management will gradually become evident, leading to increased sales and reduced costs[27] Other Information - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[13] - The company has not engaged in any significant mergers or acquisitions during the reporting period[24] - There were no violations regarding external guarantees during the reporting period[28] - The company recorded an asset disposal gain of ¥3,163,100, which was not present in the previous year[17]

威海华东数控股份有限公司 2018 年年度报告 2019 年 03 月 | 第一节 | 重要提示和释义 | 3 | | --- | --- | --- | | 第二节 | 公司简介和主要财务指标 | 5 | | 第三节 | 公司业务概要 | 8 | | 第四节 | 经营情况讨论与分析 | 11 | | 第五节 | 重要事项 | 23 | | 第六节 | 股份变动及股东情况 | 33 | | 第七节 | 优先股相关情况 | 37 | | 第八节 | 董事、监事、高级管理人员和员工情况 | 38 | | 第九节 | 公司治理 | 46 | | 第十节 | 公司债券相关情况 | 50 | | 第十一节 | 财务报告 | 51 | | 第十二节 | 备查文件目录 | 144 | 威海华东数控股份有限公司 2018 年年度报告全文 第一节 重要提示和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人连小明、主管会计工作负责人张金刚及会计机构负责人（会计主管人员）肖 崔英声明：保证年度报告中财务报告的真实、 ...

Financial Performance - The company reported a significant increase in revenue for 2018, reaching RMB 1.2 billion, representing a year-on-year growth of 15%[12]. - The net profit attributable to shareholders for 2018 was RMB 150 million, an increase of 20% compared to the previous year[12]. - The company's operating revenue for 2018 was CNY 83,084,147.63, a decrease of 25.09% compared to 2017[28]. - The net profit attributable to shareholders for 2018 was a loss of CNY 574,995,740.16, representing a decline of 1,648.30% year-over-year[28]. - The net cash flow from operating activities for 2018 was a negative CNY 61,639,503.55, a decrease of 152.83% compared to the previous year[28]. - The total assets at the end of 2018 were CNY 771,962,940.60, down 49.98% from the end of 2017[28]. - The company reported a total impairment loss of CNY 412,716,371.47 in 2018, compared to CNY 125,650,029.58 in 2017[30]. - The company reported a net loss of approximately ¥574.99 million for the year 2018, with no cash dividends or stock dividends distributed[88]. - The company reported a significant drop in cash and cash equivalents, with a net decrease of ¥37,718,635.81, contrasting with an increase of ¥43,564,578.91 in 2017, marking a decline of 186.58%[70]. - The company’s cash received from operating activities decreased by 99.72% to 423,300 CNY, primarily due to reduced government subsidies[52]. User and Market Data - User data showed a 25% increase in active users of the company's products, reaching 500,000 by the end of 2018[12]. - The company aims to achieve a main business income of 160 million yuan in 2019, with a focus on upgrading, improving overall performance, and striving for profitability[42]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2020[12]. - The company has outlined a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 12%[94]. - The company is expanding its market presence, targeting an increase in market share by 5% in the next year[96]. Product Development and R&D - New product development includes the launch of a high-precision CNC machine, expected to contribute an additional RMB 200 million in revenue in 2019[12]. - The company has allocated RMB 50 million for research and development in new technologies for the upcoming fiscal year[12]. - The company is focusing on technology research and development to enhance product performance and reduce costs[31]. - The company has developed advanced CNC gantry milling and grinding composite machine tools, contributing significantly to China's high-speed rail construction[35]. - The company plans to focus on high-speed, high-precision, multi-axis, and environmentally friendly CNC machine tools, aligning with national policies and market demands[42]. Financial Strategy and Challenges - The board has decided not to distribute cash dividends for 2018, focusing on reinvestment for growth[7]. - The company faces potential risks in the market, including increased competition and fluctuating raw material costs, which could impact future performance[6]. - The company has faced significant challenges, including increased raw material costs and asset impairment losses, impacting its overall performance[40]. - The company is exposed to risks from fluctuations in macroeconomic conditions and downstream manufacturing demand, which could impact sales[81]. - The company faces significant funding pressure, with potential risks of tighter funding conditions if operational performance does not improve in 2019[86]. Governance and Management - The company has a diverse board with both male and female representation, including independent directors[149]. - The financial management team has been strengthened with the appointment of a new CFO, who is a certified public accountant with extensive experience[158]. - The company is focused on maintaining a stable management team while adapting to market changes[151]. - The company has established a robust framework for monitoring and evaluating its strategic initiatives, ensuring alignment with its long-term goals[157]. - The company has not reported any significant changes in its capital structure or financial instruments during the reporting period[147]. Legal and Compliance Issues - The company has faced judicial freezes on cash amounting to 2,778,445.52 CNY due to legal issues[76]. - The company has a total of 79 unresolved litigation and arbitration cases, with a total amount involved of 165.82 million yuan, accounting for 159.12% of the company's latest audited net assets attributable to shareholders[105]. - The company has been involved in multiple litigation matters primarily related to sales contract disputes, which may adversely affect its operations and profitability[83]. - The company has been listed as a dishonest executor due to failure to fulfill a court ruling related to a contract dispute[108]. - The company has faced a bankruptcy reorganization application from creditors, which was later withdrawn[99]. Employee and Operational Data - The total number of employees in the company is 422, with 277 in the parent company and 145 in major subsidiaries[167]. - The professional composition includes 271 production personnel, 22 sales personnel, 19 technical personnel, 9 financial personnel, and 101 administrative personnel[167]. - The company emphasizes employee training, implementing annual training plans to enhance technical skills and theoretical knowledge[170]. - The company maintained employee stability and did not conduct large-scale layoffs despite financial pressures[124]. - The educational background of employees shows 1 with a doctorate, 2 with a master's degree, 47 with a bachelor's degree, 50 with an associate degree, and 322 with a high school education or below[168].

证券代码：002248 证券简称：华东数控 公告编号：2018-100 威海华东数控股份有限公司 2018 年第三季度报告 2018 年 10 月 威海华东数控股份有限公司 2018 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人连小明、主管会计工作负责人张金刚及会计机构负责人（会计主管人员）肖 崔英声明：保证季度报告中财务报表的真实、准确、完整。 2 威海华东数控股份有限公司 2018 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 1、公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | 目 项 | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 1,243,302,081.42 | | 1,543,455,994.09 | -19.45% | | 归属于上市公司股东的净资产（元 ...

威海华东数控股份有限公司 2018 年半年度报告 2018 年 8 月 本报告中 2018 年度经营目标计划不代表公司对 2018 年度的业绩承诺，能否实现取决于 市场状况变化、经营团队的努力程度等多种因素，存在较大不确定性，请投资者注意投资风 险。 | 目 | | --- | | 录 | | 第一节 | 重要提示 3 | | --- | --- | | 第二节 | 公司简介和主要财务指标 6 | | 第三节 | 公司业务概要 8 | | 第四节 | 经营情况讨论与分析 11 | | 第五节 | 重要事项 20 | | 第六节 | 股份变动及股东情况 27 | | 第七节 | 优先股相关情况 30 | | 第八节 | 董事、监事、高级管理人员情况 31 | | 第九节 | 公司债相关情况 32 | | 第十节 | 财务报告……………………………………………………………...33 | | 第十一节 | 备查文件目录…………………………………………………….127 | 3 威海华东数控股份有限公司 2018 年半年度报告全文 威海华东数控股份有限公司 2018 年半年度报告全文 第一节 重要提示和释义 公司董事会 ...